FDA weighs warning labels on antidepressants for pregnant women

Breakdown

• FDA is considering adding warning labels to antidepressants for pregnant women.
• Medical consensus holds that antidepressants are generally safe during pregnancy. 9s
• An advisory panel raised concerns about possible risks including autism, miscarriage, and birth defects. 14s
• Johns Hopkins reports antidepressants are not known to cause birth defects, but about 30% of exposed babies may experience neonatal adaptation syndrome. 24s
• Experts warn that untreated depression in mothers poses significant risks, as mental health conditions are the leading cause of pregnancy-related deaths. 40s